MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Healthy or diseased?

Back to society news Blogs list Cancer blog  


Subscribe To Society News RSS Feed  RSS content feed What is RSS feed?

Healthy or diseased?




Researchers from the Institute for Bioinformatics and Systemic Biology of the Helmholtz Zentrum München and the Faculty for Biology of the Ludwig-Maximilians-Universität have shown that biological indicators for diseases caused or influenced by environmental factors can be detected by the systemic analysis of the body's metabolism (metabolomics). The procedure presented here is also suitable for pre-clinical drug testing and allows for the early detection of possible side effects of a new medication.



Healthy or diseased?
Prof. Dr. Karsten Suhre

Metabolomics aims to determine the totality of all small molecules of a cell or a tissue. The exponents of bioinformatics analyzed data collected in the framework of a pre-clinical metabolomics study in healthy and diabetic mice. In each case, a subgroup of the animals was treated with the diabetes drug RoziglitazoneTM. Then, more than 800 metabolites were quantitatively determined in a blood plasma sample of a total of forty mice, representing the factors "healthy/diabetic" and "treated/untreated".

Karsten Suhre, who led the work at the Helmholtz Zentrum München, explains the results: "It transpired that in a number of cases the ratios between the concentrations of certain metabolites were much more informative than their absolute concentrations." By a subsequent clustering of the test statistics of such metabolite pairs, it is possible to identify groups of metabolites which discriminate the animals by the factors "healthy/diabetic" or "treated/untreated".

The present results show that diabetes-biomarkers can be identified by means of an objective bioinformatics analysis of complex metabolomics data obtained in high-throughput experiments. Suhre added: "This bioinformatics approach can be used, in conjunction with the new metabolomics technology platform (metaP) at the Helmholtz Zentrum München, for the automatic identification of groups of relevant biomarkers of disease. Additionally, with the pre-clinical investigation of the effect of new drugs, metabolomics permits for the early identification of possible side effects on the metabolism.

Hitherto, genetic methods and/or transcription analyses stood rather to the fore in the investigation of metabolic diseases. Now, advances in the area of mass spectroscopy allow for the extensive examination of the metabolome. "With this recent quantum leap in the area of metabolite analysis, the challenge to bioinformatics is to develop customized, numerical evaluation methods to handle the complexity of these high quantity metabolomic data sets", explains Karsten Suhre.


Posted by: Janet    Source




Did you know?
Researchers from the Institute for Bioinformatics and Systemic Biology of the Helmholtz Zentrum München and the Faculty for Biology of the Ludwig-Maximilians-Universität have shown that biological indicators for diseases caused or influenced by environmental factors can be detected by the systemic analysis of the body's metabolism (metabolomics). The procedure presented here is also suitable for pre-clinical drug testing and allows for the early detection of possible side effects of a new medication.

Medicineworld.org: Healthy or diseased?

Asthma| Hypertension| Medicine Main| Diab french| Diabetes drug info| DruginfoFrench| Type2 diabetes| Create a dust free bedroom| Allergy statistics| Cancer terms| History of cancer| Imaging techniques| Cancer Main| Bladder cancer news| Cervix cancer news| Colon cancer news| Esophageal cancer news| Gastric cancer news| Health news| Lung cancer news| Breast cancer news| Ovarian cancer news| Cancer news|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.